Cargando…

Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors

Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuanxin, Xu, Jian, Li, Zhonghuang, Zhu, Zhengguang, Zhang, Jiajie, Wu, Shuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179154/
https://www.ncbi.nlm.nih.gov/pubmed/21954347
http://dx.doi.org/10.3390/ijms12085080
_version_ 1782212489684975616
author Tian, Yuanxin
Xu, Jian
Li, Zhonghuang
Zhu, Zhengguang
Zhang, Jiajie
Wu, Shuguang
author_facet Tian, Yuanxin
Xu, Jian
Li, Zhonghuang
Zhu, Zhengguang
Zhang, Jiajie
Wu, Shuguang
author_sort Tian, Yuanxin
collection PubMed
description Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-activity correlation of indolocarbazole series compounds and modify them to improve their selectivity and activity, 3D-QSAR models were built using CoMFA and CoMSIA methods and molecular docking was used to check the results. Based on the common sketch align, two good QSAR models with high predictabilities (CoMFA model: q(2) = 0.823, r(2) = 0.979; CoMSIA model: q(2) = 0.804, r(2) = 0.967) were obtained and the contour maps obtained from both models were applied to identify the influence on the biological activity. Molecular docking was then used to confirm the results. Combined with the molecular docking results, the detail binding mode between the ligands and Tie-2 was elucidated, which enabled us to interpret the structure-activity relationship. These satisf actory results not only offered help to comprehend the action mechanism of indolocarbazole series compounds, but also provide new information for the design of new potent inhibitors.
format Online
Article
Text
id pubmed-3179154
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-31791542011-09-27 Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors Tian, Yuanxin Xu, Jian Li, Zhonghuang Zhu, Zhengguang Zhang, Jiajie Wu, Shuguang Int J Mol Sci Article Tie-2, a kind of endothelial cell tyrosine kinase receptor, is required for embryonic blood vessel development and tumor angiogenesis. Several compounds that showed potent activity toward this attractive anticancer drug target in the assay have been reported. In order to investigate the structure-activity correlation of indolocarbazole series compounds and modify them to improve their selectivity and activity, 3D-QSAR models were built using CoMFA and CoMSIA methods and molecular docking was used to check the results. Based on the common sketch align, two good QSAR models with high predictabilities (CoMFA model: q(2) = 0.823, r(2) = 0.979; CoMSIA model: q(2) = 0.804, r(2) = 0.967) were obtained and the contour maps obtained from both models were applied to identify the influence on the biological activity. Molecular docking was then used to confirm the results. Combined with the molecular docking results, the detail binding mode between the ligands and Tie-2 was elucidated, which enabled us to interpret the structure-activity relationship. These satisf actory results not only offered help to comprehend the action mechanism of indolocarbazole series compounds, but also provide new information for the design of new potent inhibitors. Molecular Diversity Preservation International (MDPI) 2011-08-10 /pmc/articles/PMC3179154/ /pubmed/21954347 http://dx.doi.org/10.3390/ijms12085080 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Tian, Yuanxin
Xu, Jian
Li, Zhonghuang
Zhu, Zhengguang
Zhang, Jiajie
Wu, Shuguang
Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title_full Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title_fullStr Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title_full_unstemmed Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title_short Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors
title_sort combined 3d-qsar and docking modelling study on indolocarbazole series compounds as tie-2 inhibitors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179154/
https://www.ncbi.nlm.nih.gov/pubmed/21954347
http://dx.doi.org/10.3390/ijms12085080
work_keys_str_mv AT tianyuanxin combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors
AT xujian combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors
AT lizhonghuang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors
AT zhuzhengguang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors
AT zhangjiajie combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors
AT wushuguang combined3dqsaranddockingmodellingstudyonindolocarbazoleseriescompoundsastie2inhibitors